The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease

The field of Alzheimer’s research has been dominated — and divided — by a hypothesis holding that toxic clumps in the brain are the main driver of the disease and that removing them will slow cognitive decline.

Read the full post at Health
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive